It sounds as though Dr Arad had worked out the chemical compound to take the place of the root compound. It’s been mentioned more than once. GC says they can supply
Gerald discusses supply and demand for the natural product in the recent Todos Medical Business Update Conference Call, and their plans to meet expected worldwide demand by formulating a chemical compound version of Tollovir that targets the same receptor site as the natural version. Lots of great info in the presentation and Q & A session afterwards.